CASP3 and neoplasm: In the present study, we therefore examined Caspase-3 as a prognostic marker in stage 2/3 as well as in metastatic CRC patients, and further explored the role of caspase-3 as a potential predictive biomarker for 5FU-based CT and therapeutic target in CRC using primary human tumour explant culture.